Investigation: a review of the device history record confirmed that the device was manufactured and tested according to relevant procedures,and shipped according to manufacturer's specifications.Surgeon, information analysis: on 24-jan-2024 apifix was notified that patient #(b)(6) , index procedure (b)(6) 2018, had the implant removed on (b)(6) 2023 due to a loose "cap" in the area of the ratchet mechanism.Apifx followed up with the reporter directly for additional information.Despite the attempts, no additional information had been provided. on 20-feb-2024 additional information was received.According to the surgeon, "patient #249 (albsn), 'ratchet cover loosening' - i already have the implant to send you.Indeed, the cover of the ratchet mechanism came loose (in fact, it was lost during the sterilization process).I will ask for an xray during march to assess the maintenance of the correction and flexibility of the curve.Locally, i don't think there was a spontaneous fusion." risk assessment: reoperation events are a known risk that was assessed and recorded by the product risk assessment.The risk of cover disconnection from base has been assessed and found to be acceptable.The risk has been quantified, characterized, and documented as acceptable within full risk assessment.The device is expected to be returned where a failure analysis will be conducted.Once additional relevant details become available; a supplemental report will be submitted.
|